Hiroshi Satonaka Selected Research

Hiroshi Satonaka Research Topics

Disease

4	Inflammation (Inflammations) 10/2014 - 03/2004
3	Atherosclerosis 10/2014 - 03/2004
3	Infections 03/2005 - 05/2002
2	Acute Kidney Injury (Acute Renal Failure) 03/2024 - 01/2006
2	Hypertension (High Blood Pressure) 03/2024 - 01/2020
2	Glomerulonephritis 11/2019 - 07/2005
2	Renal Insufficiency (Renal Failure) 11/2019 - 01/2006
2	Proteinuria 10/2014 - 07/2005
2	Hemorrhage 05/2013 - 06/2010
2	Diabetes Mellitus 04/2005 - 03/2005
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 03/2024
1	Diabetic Nephropathies (Diabetic Nephropathy) 03/2024
1	Nephrotic Syndrome (Syndrome, Nephrotic) 12/2021
1	Albuminuria 12/2021
1	Type 2 Diabetes Mellitus (MODY) 10/2020
1	Starvation 10/2020
1	Headache (Headaches) 11/2019
1	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 11/2019
1	Fever (Fevers) 11/2019
1	Hyperemia 10/2014
1	Chronic Renal Insufficiency 10/2014
1	Dyslipidemias (Dyslipidemia) 10/2014
1	Liver Diseases (Liver Disease) 06/2010
1	Hypoxia (Hypoxemia) 02/2009
1	Ischemia 01/2006
1	Reperfusion Injury 01/2006
1	Vascular Diseases (Vascular Disease) 03/2005
1	Body Weight (Weight, Body) 07/2004
1	Cardiomegaly (Heart Hypertrophy) 03/2004
1	Hypertrophy 05/2002

Drug/Important Bio-Agent (IBA)

2	CytokinesIBA 12/2011 - 03/2005
2	Proteins (Proteins, Gene)FDA Link 07/2005 - 05/2002
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2004 - 03/2004
2	Angiotensin IIIBA 07/2004 - 05/2002
2	MAP Kinase Kinase 6IBA 07/2004 - 05/2002
1	GlucosidasesIBA 03/2024
1	CreatinineIBA 03/2024
1	miglitol (Glyset)FDA Link 03/2024
1	PuromycinIBA 12/2021
1	NucleosidesIBA 12/2021
1	Adenosine Triphosphatases (ATPase)IBA 10/2020
1	Glucose (Dextrose)FDA LinkGeneric 10/2020
1	bafilomycin B1IBA 10/2020
1	Antihypertensive Agents (Antihypertensives)IBA 01/2020
1	Rituximab (Mabthera)FDA Link 11/2019
1	Immunoglobulin G (IgG)IBA 11/2019
1	antiglomerular basement membrane antibodyIBA 11/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2014
1	Ezetimibe (Zetia)FDA Link 10/2014
1	Atorvastatin (Lipitor)FDA Link 10/2014
1	LipidsIBA 10/2014
1	CholesterolIBA 10/2014
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 10/2014
1	AdiponectinIBA 10/2014
1	OsteopontinIBA 12/2011
1	AldosteroneIBA 12/2011
1	Factor XIII (Coagulation Factor XIII)IBA 06/2010
1	Caspase 3 (Caspase-3)IBA 02/2009
1	AMP-Activated Protein KinasesIBA 02/2009
1	Insulin Receptor Substrate ProteinsIBA 01/2006
1	GhrelinIBA 01/2006
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2005
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 07/2005
1	DilazepIBA 07/2005
1	imidaprilIBA 07/2005
1	AdrenomedullinIBA 04/2005
1	Fluvastatin FDA Link 04/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2005
1	semapimodIBA 03/2005
1	Advanced Glycation End ProductsIBA 03/2005
1	Interleukin-6 (Interleukin 6)IBA 03/2005
1	AICA ribonucleotide (ZMP)IBA 07/2004
1	Messenger RNA (mRNA)IBA 07/2004
1	MEF2 Transcription FactorsIBA 07/2004
1	CalcineurinIBA 03/2004
1	Calcineurin InhibitorsIBA 05/2002
1	nonmuscle myosin type IIB heavy chainIBA 05/2002

Therapy/Procedure

2	Therapeutics 11/2019 - 06/2010
1	Intraperitoneal Injections 10/2020
1	Renal Dialysis (Hemodialysis) 05/2013
1	Subcutaneous Injections 07/2004